Coherus BioSciences
CHRS
$2.07
Share price
1.47%
Change (1 day)
-71.37%
Change (1 year)
Categories
EPS for Coherus BioSciences (CHRS)
EPS in 2023 (TTM): -$3.32
According to Coherus BioSciences 's latest financial reports the company's current EPS (TTM) is -$3.32. In 2022 the company made an earnings per share (EPS) of -$3.76 an increase over its 2021 EPS that were of -$3.86.
EPS history for Coherus BioSciences from 2014 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$3.32 | -11.7% |
| 2022 | -$3.76 | -2.59% |
| 2021 | -$3.86 | -308.65% |
| 2020 | $1.85 | 44.53% |
| 2019 | $1.28 | -139.88% |
| 2018 | -$3.21 | -29.45% |
| 2017 | -$4.55 | 43.53% |
| 2016 | -$3.17 | -47.08% |
| 2015 | -$5.99 | 33.48% |
| 2014 | -$4.49 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $14.15 | -526.20% | 🇺🇸 USA |
 Repligen
RGEN | $2.09 | -162.95% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | -$9.78 | 194.50% | 🇺🇸 USA |